Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04465643
Title Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

malignant peripheral nerve sheath tumor

atypical neurofibroma

optic nerve glioma

plexiform neurofibroma

high grade glioma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.